X
GO

The Role of the Pharmacist in the Management of Chronic Obstructive Pulmonary Disease

NJSHP Central Chapter Meeting - 10/24/18

Saturday, October 13, 2018

Germin Fahim, PharmD, BCPS

 

In the last few years, the number of inhalation devices available in the market has grown tremendously, which requires clinicians to maintain familiarity with all of these devices, so pharmacologic therapy can be individualized for all COPD patients. Given the increased complexity of inhaler management, including patient selection and counseling on inhaler technique, as well as the well-recognized importance of adherence in COPD management, the pharmacist is uniquely positioned to have a significant impact on the achievement of positive outcomes in these patients, especially readmission rates.

Print

x

About the Central Chapter

The Central Chapter Membership includes members who either live or work in the counties of Hunterdon, Mercer, Middlesex, Monmouth, Ocean, and Somerset.

President: Maria Cardinale
President-Elect: Toral Patel
Secretary: Lawrence (Larry) Kaiserman
Treasurer: Alex Kardos

Central Chapter News

Central Chapter

Beta Lactam Antibiotics and Skin Testing

Saint Peter's University Medical Center

New Brunswick, NJ 08901

Registration: 6:00 PM

Please plan to attend.


The Role of the Pharmacist in the Management of Chronic Obstructive Pulmonary Disease

NJSHP Central Chapter Meeting - 10/24/18

This program will review the role of the pharmacist in the management of COPD. Please join us as Dr. Fahim walks us through the pathophysiology of Chronic Obstructive Pulmonary Disorder (COPD), summarizes current treatment guidelines and identify emerging drug therapies for COPD, and discusses the pharmacist’s role in the management of COPD.
RSS